Novel models for predicting individualized outcomes in patients with advanced hepatocellular carcinoma receiving immunotherapy - Top-Institutions - MDSpire

Novel models for predicting individualized outcomes in patients with advanced hepatocellular carcinoma receiving immunotherapy

  • By

  • Chao Chen

  • Yang Wang

  • Yan Zhao

  • Wenyan Cao

  • Ao Chen

  • Xiufeng Liu

  • Zhan Shi

  • Jie Shen

  • June 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Sydney
    The University of Sydney

    Sydney, NSW

    Key Differentiators

    • Oncology

  • #2

    Gustave Roussy
    Gustave Roussy

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

  • #3

    The First Affiliated Hospital of Jinan University
    The First Affiliated Hospital of Jinan University

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology

  • #4

    The Cancer Genome Atlas
    The Cancer Genome Atlas

    N/A, N/A

    Key Differentiators

    • Oncology

Original Source(s)

Novel models for predicting individualized outcomes in patients with advanced hepatocellular carcinoma receiving immunotherapy

  • by Chao Chen, Yang Wang, Yan Zhao, Wenyan Cao, Ao Chen, Xiufeng Liu, Zhan Shi, Jie Shen

  • June 1, 2026

Related Content

Reduced-intensity versus intensive induction in high-risk acute promyelocytic leukemia: a systematic review and meta-analysis

Longitudinal changes in nutritional status during induction chemotherapy and their association with treatment outcomes in pediatric patients with newly diagnosed acute myeloid leukemia

Spatial single-cell omics: new insights into liver diseases